Mitoxantrone HCL Liposome Injection
Sponsors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions
Relapsed Cutaneous T Cell LymphomRelapsed DLBCL and PT/NKCLs
Phase 2
Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs
NCT02597387
Start: 2015-08-31End: 2018-10-31Target: 50Updated: 2018-08-17
Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas
TerminatedNCT02597153
Start: 2015-10-31End: 2020-10-31Updated: 2017-05-24